论文部分内容阅读
实体肿瘤的非血管内介入治疗是肿瘤介入治疗的重要方法之一。正确全面评估肿瘤血供、内部结构和分子生物学行为是选择非血管介入治疗的前提;非血管内治疗是血管内介入治疗的有效补充和进一步完善。其选择原则应遵从损伤小,价格廉价首选,与此同时,应该充分考虑到不同方法的适应证,另外谨慎过渡治疗。
Non-endovascular treatment of solid tumors is one of the important methods of interventional therapy. Correct and comprehensive assessment of tumor blood supply, internal structure and molecular biological behavior is the prerequisite for non-vascular intervention; non-endovascular treatment is an effective supplement and further improvement of endovascular interventional therapy. The principle of choice should follow the small damage, the first choice for cheap prices, at the same time, should take full account of the indications of different methods, in addition to cautious transitional treatment.